11-615011-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001572.5(IRF7):​c.184-4T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,542,720 control chromosomes in the GnomAD database, including 61,954 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 9266 hom., cov: 35)
Exomes 𝑓: 0.27 ( 52688 hom. )

Consequence

IRF7
NM_001572.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00009671
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.444

Publications

17 publications found
Variant links:
Genes affected
IRF7 (HGNC:6122): (interferon regulatory factor 7) This gene encodes interferon regulatory factor 7, a member of the interferon regulatory transcription factor (IRF) family. It has been shown to play a role in the transcriptional activation of virus-inducible cellular genes, including interferon beta chain genes. Inducible expression of IRF7 is largely restricted to lymphoid tissue. The encoded protein plays an important role in the innate immune response against DNA and RNA viruses. [provided by RefSeq, Jul 2021]
IRF7 Gene-Disease associations (from GenCC):
  • immunodeficiency 39
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 11-615011-A-T is Benign according to our data. Variant chr11-615011-A-T is described in ClinVar as [Benign]. Clinvar id is 1170391.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.509 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRF7NM_001572.5 linkc.184-4T>A splice_region_variant, intron_variant Intron 3 of 10 ENST00000525445.6 NP_001563.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRF7ENST00000525445.6 linkc.184-4T>A splice_region_variant, intron_variant Intron 3 of 10 5 NM_001572.5 ENSP00000434009.2 Q92985-1

Frequencies

GnomAD3 genomes
AF:
0.324
AC:
49144
AN:
151834
Hom.:
9250
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.515
Gnomad AMI
AF:
0.205
Gnomad AMR
AF:
0.306
Gnomad ASJ
AF:
0.346
Gnomad EAS
AF:
0.0258
Gnomad SAS
AF:
0.131
Gnomad FIN
AF:
0.185
Gnomad MID
AF:
0.333
Gnomad NFE
AF:
0.270
Gnomad OTH
AF:
0.330
GnomAD2 exomes
AF:
0.248
AC:
40610
AN:
163470
AF XY:
0.239
show subpopulations
Gnomad AFR exome
AF:
0.510
Gnomad AMR exome
AF:
0.318
Gnomad ASJ exome
AF:
0.339
Gnomad EAS exome
AF:
0.0282
Gnomad FIN exome
AF:
0.186
Gnomad NFE exome
AF:
0.261
Gnomad OTH exome
AF:
0.255
GnomAD4 exome
AF:
0.266
AC:
369688
AN:
1390768
Hom.:
52688
Cov.:
37
AF XY:
0.261
AC XY:
179109
AN XY:
685460
show subpopulations
African (AFR)
AF:
0.520
AC:
16740
AN:
32176
American (AMR)
AF:
0.316
AC:
12276
AN:
38832
Ashkenazi Jewish (ASJ)
AF:
0.335
AC:
7684
AN:
22914
East Asian (EAS)
AF:
0.0224
AC:
860
AN:
38312
South Asian (SAS)
AF:
0.145
AC:
11246
AN:
77376
European-Finnish (FIN)
AF:
0.199
AC:
7349
AN:
36850
Middle Eastern (MID)
AF:
0.306
AC:
1703
AN:
5566
European-Non Finnish (NFE)
AF:
0.274
AC:
296115
AN:
1081060
Other (OTH)
AF:
0.272
AC:
15715
AN:
57682
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
15227
30454
45682
60909
76136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10168
20336
30504
40672
50840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.324
AC:
49196
AN:
151952
Hom.:
9266
Cov.:
35
AF XY:
0.313
AC XY:
23261
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.515
AC:
21312
AN:
41380
American (AMR)
AF:
0.306
AC:
4672
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.346
AC:
1200
AN:
3466
East Asian (EAS)
AF:
0.0259
AC:
134
AN:
5176
South Asian (SAS)
AF:
0.129
AC:
625
AN:
4832
European-Finnish (FIN)
AF:
0.185
AC:
1961
AN:
10612
Middle Eastern (MID)
AF:
0.341
AC:
99
AN:
290
European-Non Finnish (NFE)
AF:
0.270
AC:
18311
AN:
67900
Other (OTH)
AF:
0.329
AC:
695
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1674
3348
5023
6697
8371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.203
Hom.:
641
Bravo
AF:
0.345
Asia WGS
AF:
0.127
AC:
440
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency 39 Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 07, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 59% of patients studied by a panel of primary immunodeficiencies. Number of patients: 56. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.4
DANN
Benign
0.92
PhyloP100
-0.44
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000097
dbscSNV1_RF
Benign
0.028
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12272434; hg19: chr11-615011; API